Rab7-a novel redox target that modulates inflammatory pain processing

Wiebke Kallenborn-Gerhardt1,2, Christine V Möser2, Jana E Lorenz2

  • 1Institute of Pharmacology, College of Pharmacy, Goethe University, Frankfurt am Main, Germany.

Pain
|April 11, 2017
PubMed

Insights

Reactive oxygen species (ROS) contribute to chronic pain. This study identifies Rab7, a small GTPase, as a key redox-modified target in sensory neurons, revealing its role in modulating inflammatory pain.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pain Research

Background:

  • Chronic pain involves reactive oxygen species (ROS) in nociceptive processing.
  • Molecular targets of ROS signaling in pain pathways are not well understood.

Purpose of the Study:

  • To identify molecular targets of redox regulation in pain pathways.
  • To investigate the role of the small GTPase Rab7 in inflammatory pain.

Main Methods:

  • Proteome screen using OxICAT to identify redox-modified proteins.
  • Investigated Rab7 GTPase activity upon modification of redox-sensing thiols.
  • Utilized immunofluorescence and knockout mice lacking Rab7 in sensory neurons.

Main Results:

  • Rab7 was identified as a redox-modified target during inflammatory pain.
  • Rab7 oxidation influences its GTPase activity.
  • Reduced inflammatory pain behavior was observed in mice lacking Rab7 in sensory neurons.

Conclusions:

  • Redox-dependent modification of Rab7 activity modulates inflammatory pain sensitivity.
  • Rab7 is a novel molecular player in ROS-mediated pain signaling.

Related Concept Videos

Nociception01:44

Nociception

Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain. Thus, pain helps the...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...